Karin Rodland

ORCID: 0000-0001-7070-6541
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Seismic Waves and Analysis
  • Earthquake Detection and Analysis
  • Methane Hydrates and Related Phenomena
  • Ionosphere and magnetosphere dynamics
  • Geophysics and Gravity Measurements
  • Seismology and Earthquake Studies
  • Advanced Proteomics Techniques and Applications
  • Geophysical Methods and Applications
  • Mass Spectrometry Techniques and Applications
  • Astrophysics and Cosmic Phenomena
  • Cytokine Signaling Pathways and Interactions
  • Molecular Biology Techniques and Applications
  • Cancer Genomics and Diagnostics
  • Acute Myeloid Leukemia Research
  • Ferroptosis and cancer prognosis
  • Bioinformatics and Genomic Networks
  • Protein Kinase Regulation and GTPase Signaling
  • Multiple Myeloma Research and Treatments
  • Advanced Biosensing Techniques and Applications
  • RNA modifications and cancer
  • Ubiquitin and proteasome pathways
  • Protein Degradation and Inhibitors
  • Metabolomics and Mass Spectrometry Studies
  • Gene expression and cancer classification
  • Cancer, Lipids, and Metabolism

Pacific Northwest National Laboratory
2016-2025

Oregon Health & Science University
2001-2025

Government of the United States of America
2023

Environmental Molecular Sciences Laboratory
2002-2021

Battelle
2003-2020

Fusion (United States)
2020

Fusion Academy
2020

Clinical Research Consortium
2020

Research Network (United States)
2018

Richland College
2017

10.1016/j.cell.2016.05.069 article EN publisher-specific-oa Cell 2016-07-01

ABSTRACT Human cytomegalovirus (HCMV), a member of the herpesvirus family, is large complex enveloped virus composed both viral and cellular gene products. While sequence HCMV genome has been known for over decade, full set proteins that compose virion are unknown. To approach this problem we have utilized gel-free two-dimensional capillary liquid chromatography-tandem mass spectrometry (MS/MS) Fourier transform ion cyclotron resonance MS to identify determine relative abundances in purified...

10.1128/jvi.78.20.10960-10966.2004 article EN Journal of Virology 2004-09-27

Glioblastoma (GBM) is the most aggressive nervous system cancer. Understanding its molecular pathogenesis crucial to improving diagnosis and treatment. Integrated analysis of genomic, proteomic, post-translational modification metabolomic data on 99 treatment-naive GBMs provides insights GBM biology. We identify key phosphorylation events (e.g., phosphorylated PTPN11 PLCG1) as potential switches mediating oncogenic pathway activation, well targets for EGFR-, TP53-, RB1-altered tumors. Immune...

10.1016/j.ccell.2021.01.006 article EN cc-by-nc-nd Cancer Cell 2021-02-11

The integration of mass spectrometry-based proteomics with next-generation DNA and RNA sequencing profiles tumors more comprehensively. Here this "proteogenomics" approach was applied to 122 treatment-naive primary breast cancers accrued preserve post-translational modifications, including protein phosphorylation acetylation. Proteogenomics challenged standard cancer diagnoses, provided detailed analysis the ERBB2 amplicon, defined tumor subsets that could benefit from immune checkpoint...

10.1016/j.cell.2020.10.036 article EN cc-by-nc-nd Cell 2020-11-01

We undertook a comprehensive proteogenomic characterization of 95 prospectively collected endometrial carcinomas, comprising 83 endometrioid and 12 serous tumors. This analysis revealed possible new consequences perturbations to the p53 Wnt/β-catenin pathways, identified potential role for circRNAs in epithelial-mesenchymal transition, provided information about proteomic markers clinical genomic tumor subgroups, including relationships known druggable pathways. An extensive genome-wide...

10.1016/j.cell.2020.01.026 article EN cc-by Cell 2020-02-01

Protein abundance and phosphorylation convey important information about pathway activity molecular pathophysiology in diseases including cancer, providing biological insight, informing drug diagnostic development, guiding therapeutic intervention. Analyzed tissues are usually collected without tight regulation or documentation of ischemic time. To evaluate the impact ischemia, we human ovarian tumor breast cancer xenograft tissue vascular interruption performed quantitative proteomics...

10.1074/mcp.m113.036392 article EN cc-by Molecular & Cellular Proteomics 2014-04-10
Francesca Petralia Nicole Tignor Boris Reva Mateusz Koptyra Shrabanti Chowdhury and 95 more Dmitry Rykunov Azra Krek Weiping Ma Yuankun Zhu Jiayi Ji Anna Calinawan Jeffrey R. Whiteaker Antonio Colaprico Vasileios Stathias Tatiana Omelchenko Xiaoyu Song Pichai Raman Yiran Guo Miguel Brown Richard G. Ivey John Szpyt Sanjukta Guha Thakurta Marina Gritsenko Karl Weitz Gonzalo López Selim Kalaycı Zeynep H. Gümüş Seungyeul Yoo Felipe da Veiga Leprevost Hui-Yin Chang Karsten Krug Lizabeth Katsnelson Ying Wang Jacob J. Kennedy Uliana J. Voytovich Lei Zhao Krutika S. Gaonkar Brian Ennis Bo Zhang Valérie Baubet Lamiya Tauhid Jena Lilly Jennifer Mason Bailey Farrow Nathan Young Sarah Leary Jamie Moon Vladislav Petyuk Javad Nazarian Nithin D. Adappa James N. Palmer Robert M. Lober Samuel Rivero-Hinojosa Liang-Bo Wang Joshua M. Wang Matilda Broberg Rosalie Chu Ronald J. Moore Matthew Monroe Rui Zhao Richard Smith Jun Zhu Ana I. Robles Mehdi Mesri Emily S. Boja Tara Hiltke Henry Rodriguez Bing Zhang Eric E. Schadt D.R. Mani Li Ding Antonio Iavarone Maciej Wiznerowicz Stephan C. Schürer Xi S. Chen Allison P. Heath Jo Lynne Rokita Alexey I. Nesvizhskii David Fenyö Karin Rodland Tao Liu Steven P. Gygi Amanda G. Paulovich Adam Resnick Phillip B. Storm Brian R. Rood Pei Wang Alicia Francis Allison M. Morgan Angela J. Waanders Angela N. Viaene Anna Maria Buccoliero Arul M. Chinnaiyan Carina A. Leonard Cassie Kline Chiara Caporalini Christopher R. Kinsinger Chunde Li David E. Kram Derek Hanson

We report a comprehensive proteogenomics analysis, including whole-genome sequencing, RNA and proteomics phosphoproteomics profiling, of 218 tumors across 7 histological types childhood brain cancer: low-grade glioma (n = 93), ependymoma (32), high-grade (25), medulloblastoma (22), ganglioglioma (18), craniopharyngioma (16), atypical teratoid rhabdoid tumor (12). Proteomics data identify common biological themes that span boundaries, suggesting treatments used for one type may be applied...

10.1016/j.cell.2020.10.044 article EN cc-by-nc-nd Cell 2020-11-25

Sensitive detection of low-abundance proteins in complex biological samples has typically been achieved by immunoassays that use antibodies specific to target proteins; however, de novo development is associated with high costs, long lead times, and failure rates. To address these challenges, we developed an antibody-free strategy involves PRISM (high-pressure, high-resolution separations coupled intelligent selection multiplexing) for sensitive selected reaction monitoring (SRM)–based...

10.1073/pnas.1204366109 article EN Proceedings of the National Academy of Sciences 2012-09-04

For many years, basic and clinical researchers have taken advantage of the analytical sensitivity specificity afforded by mass spectrometry in measurement proteins. Clinical laboratories are now beginning to deploy these work flows as well. assays that use proteolysis generate peptides for protein quantification characterization, synthetic stable isotope-labeled internal standard central importance. No general recommendations currently available surrounding spectrometric assays.The Proteomic...

10.1373/clinchem.2015.250563 article EN Clinical Chemistry 2015-12-30

Mass spectrometry (MS)-based proteomics has great potential for overcoming the limitations of antibody-based immunoassays antibody-independent, comprehensive, and quantitative proteomic analysis single cells. Indeed, recent advances in nanoscale sample preparation have enabled effective processing In particular, concept using boosting/carrier channels isobaric labeling to increase sensitivity MS detection also been increasingly used small-sized samples including However, full such approaches...

10.1074/mcp.ra119.001857 article EN cc-by Molecular & Cellular Proteomics 2020-03-04
Yize Li T. Mamie Lih Saravana M. Dhanasekaran Rahul Mannan Lijun Chen and 95 more Marcin Cieślik Yige Wu Rita Jiu-Hsien Lu David Clark Iga Kołodziejczak Runyu Hong Siqi Chen Yanyan Zhao Seema Chugh Wagma Caravan Nataly Naser Al Deen Noshad Hosseini Chelsea J. Newton Karsten Krug Yuanwei Xu Kyung-Cho Cho Yingwei Hu Yuping Zhang Chandan Kumar‐Sinha Weiping Ma Anna Calinawan Matthew A. Wyczalkowski Michael C. Wendl Yuefan Wang Shenghao Guo Cissy Zhang Anne Le Aniket Dagar Alex Hopkins Hanbyul Cho Felipe da Veiga Leprevost Xiaojun Jing Guo Ci Teo Wenke Liu Melissa A. Reimers Russell K. Pachynski Alexander J. Lazar Arul M. Chinnaiyan Brian Andrew Van Tine Bing Zhang Karin Rodland Gad Getz D.R. Mani Pei Wang Feng Chen Galen Hostetter Mathangi Thiagarajan W. Marston Linehan David Fenyö Scott D. Jewell Gilbert S. Omenn Rohit Mehra Maciej Wiznerowicz Ana I. Robles Mehdi Mesri Tara Hiltke Eunkyung An Henry Rodriguez Daniel W. Chan Christopher J. Ricketts Alexey I. Nesvizhskii Hui Zhang Li Ding Alicia Francis Amanda G. Paulovich Andrzej Antczak Anthony R. Green Antonio Colaprico A. Ari Hakimi Barb Pruetz Barbara Hindenach Birendra Kumar Yadav Boris Reva Brenda Fevrier-Sullivan Brian J. Druker Cezary Szczylik Charles A. Goldthwaite Chet Birger Corbin D. Jones Daniel C. Rohrer Darlene Tansil David Chesla David I. Heiman Elizabeth R. Duffy Eri E. Schadt Francesca Petralia Gabriel Bromiński Gabriela Quiroga‐Garza George D. Wilson Ginny Xiaohe Li Grace Zhao Yi Hsiao James J. Hsieh Jan Lubiński Jasmin Bavarva

Clear cell renal carcinomas (ccRCCs) represent ∼75% of RCC cases and account for most RCC-associated deaths. Inter- intratumoral heterogeneity (ITH) results in varying prognosis treatment outcomes. To obtain the comprehensive profile ccRCC, we perform integrative histopathologic, proteogenomic, metabolomic analyses on 305 ccRCC tumor segments 166 paired adjacent normal tissues from 213 cases. Combining histologic molecular profiles reveals ITH 90% ccRCCs, with 50% demonstrating immune...

10.1016/j.ccell.2022.12.001 article EN cc-by-nc-nd Cancer Cell 2022-12-22
Yifat Geffen Shankara Anand Yo Akiyama Tomer M. Yaron Yizhe Song and 95 more Jared L. Johnson Akshay Govindan Özgün Babur Yize Li Emily M. Huntsman Liang-Bo Wang Chet Birger David I. Heiman Qing Zhang Mendy Miller Yosef E. Maruvka Nicholas J. Haradhvala Anna Calinawan Saveliy Belkin Alexander Kerelsky Karl R. Clauser Karsten Krug Shankha Satpathy Samuel Payne D.R. Mani Michael A. Gillette Saravana M. Dhanasekaran Mathangi Thiagarajan Mehdi Mesri Henry Rodriguez Ana I. Robles Steven A. Carr Alexander J. Lazar François Aguet Lewis C. Cantley Li Ding Gad Getz Eunkyung An Meenakshi Anurag Jasmin Bavarva Michael J. Birrer Özgün Babur Song Cao Michele Ceccarelli Daniel W. Chan Arul M. Chinnaiyan Hanbyul Cho Shrabanti Chowdhury Marcin Cieślik Antonio Colaprico Steven A. Carr Felipe da Veiga Leprevost Corbin Day Marcin J. Domagalski Yongchao Dou Brian J. Druker Nathan Edwards Matthew J. Ellis David Fenyö Steven M. Foltz Alicia Francis Tania J González-Robles Sara J.C. Gosline Zeynep H. Gümüş Tara Hiltke Runyu Hong Galen Hostetter Yingwei Hu Chen Huang Antonio Iavarone Eric J. Jaehnig Scott Jewel Jiayi Ji Wen Jiang Lizabeth Katsnelson Karen A. Ketchum Iga Kołodziejczak Chandan Kumar‐Sinha Karsten Krug Jonathan T. Lei Wen-Wei Liang Yuxing Liao Caleb M. Lindgren Tao Liu Wenke Liu Weiping Ma Wilson McKerrow Mehdi Mesri D.R. Mani Alexey I. Nesvizhskii Chelsea J. Newton Robert Oldroyd Gilbert S. Omenn Amanda G. Paulovich Francesca Petralia Pietro Pugliese Boris Reva Karin Rodland Kelly V. Ruggles Dmitry Rykunov

Post-translational modifications (PTMs) play key roles in regulating cell signaling and physiology both normal cancer cells. Advances mass spectrometry enable high-throughput, accurate, sensitive measurement of PTM levels to better understand their role, prevalence, crosstalk. Here, we analyze the largest collection proteogenomics data from 1,110 patients with profiles across 11 types (10 National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium [CPTAC]). Our study reveals...

10.1016/j.cell.2023.07.013 article EN cc-by-nc-nd Cell 2023-08-01

Changes in the concentration of extracellular calcium can affect balance between proliferation and differentiation several cell types, including keratinocytes, breast epithelial cells, fibroblasts. This report demonstrates that elevation stimulates proliferation-associated signaling pathways rat fibroblasts implicates calcium-sensing receptors (CaR) as mediators this response. Rat-1 express CaR mRNA protein respond to known agonists with increased IP3 production release intracellular...

10.1074/jbc.273.2.1114 article EN cc-by Journal of Biological Chemistry 1998-01-01

INTRODUCTION: The advent of high throughput technologies capable comprehensive analysis genes, transcripts, proteins and other significant biological molecules has provided an unprecedented opportunity for the identification molecular markers disease processes. However, it simultaneously complicated problem extracting meaningful signatures processes from these complex datasets. process biomarker discovery characterization provides opportunities more sophisticated approaches to integrating...

10.1517/17530059.2012.718329 article EN Expert Opinion on Medical Diagnostics 2012-08-27

Abstract Endothelin is a potent vasoconstrictive peptide recently isolated by Yanagisawa, M., Kurihara, H., Kimura, S., Tamobe, Y., Kobayashi, Mitsui, Yazaki, Goto, K., and Masaki, T. (1988) Nature 332, 411-415). In order to understand the mechanism of action endothelin in various cell types we have examined effects on second messenger levels Rat-1 fibroblasts A10 smooth muscle cells. stimulated 15-fold increase accumulation inositol trisphosphate cells, with half-maximal stimulation...

10.1016/s0021-9258(18)81823-3 article EN cc-by Journal of Biological Chemistry 1989-05-01

Coexpression of mRNAs under multiple conditions is commonly used to infer cofunctionality their gene products despite well-known limitations this "guilt-by-association" (GBA) approach. Recent advancements in mass spectrometry-based proteomic technologies have enabled global expression profiling at the protein level; however, whether proteome data can outperform transcriptome for coexpression based function prediction has not been systematically investigated. Here, we address question by...

10.1074/mcp.m116.060301 article EN cc-by Molecular & Cellular Proteomics 2016-11-12

Various genetic mutations associated with cancer are known to alter cell signaling, but it is not clear whether they dysregulate signaling pathways by altering the abundance of pathway proteins. Using a combination RNA sequencing and ultrasensitive targeted proteomics, we defined primary components-16 core proteins 10 feedback regulators-of epidermal growth factor receptor (EGFR)-mitogen-activated protein kinase (MAPK) in normal human mammary epithelial cells then quantified their absolute...

10.1126/scisignal.aaf0891 article EN Science Signaling 2016-07-12

Protein modification by O-linked β-N-acetylglucosamine (O-GlcNAc) is emerging as an important factor in the pathogenesis of sporadic Alzheimer's disease (AD); however, detailed molecular characterization this protein post-translational at proteome level has been highly challenging, owing to its low stoichiometry and labile nature. Herein, we report most comprehensive, quantitative proteomics analysis for O-GlcNAcylation postmortem human brain tissues with without AD use isobaric tandem mass...

10.1002/path.4929 article EN The Journal of Pathology 2017-06-28

Many gene products exhibit great structural heterogeneity because of an array modifications. These modifications are not directly encoded in the genomic template but often affect functionality proteins. Protein glycosylation plays a vital role proper protein functions. However, analysis glycoproteins has been challenging compared with other modifications, such as phosphorylation. Here, we perform integrated proteomic and glycoproteomic 83 prospectively collected high-grade serous ovarian...

10.1016/j.celrep.2020.108276 article EN cc-by Cell Reports 2020-10-01
Coming Soon ...